Συγκριτική ανάλυση μεταξύ FDA και EMA

Μπαρτζώκα, Αντιγόνη

Comparative analysis between FDA and EMA

Master Thesis

Author

Μπαρτζώκα, Αντιγόνη

Date

2022

Advisor

Ψυλλάκη, Μαρία

View/Open

Μεταπτυχιακή διατριβή (973.7Kb)

Keywords

EMA ; FDA

Abstract

The European Medicines Agency (EMA) and the FDA have common objectives, including protecting public health, evaluating the safety and efficacy of therapeutic products, working with external experts, providing information on legislation and health and supporting product development. However, these organizations differ in terms of structure, review times for medicinal products and benefit-risk assessment. In conclusion, it is important to establish a safety net for the beneficiaries of the right to health, who are citizens (Adashi et al., 2022). The management of health problems should be carried out in the same way in all states. Essentially, member states should communicate with each other to develop their action plans to achieve the highest level of healthcare (Adashi et al., 2022). In this way, citizens will have confidence in the power of the legal system and the pharmaceutical materials it produces.